Serum Concentration of HE4, a New Marker for Ovarian Cancer, Changes Little Throughout IVF Stimulation
N/A
27 Years
39 Years
27 Years
39 Years
Open (Enrolling)
Female
IVF Treatment, Human Epididymal Secretory Protein E4
Female
IVF Treatment, Human Epididymal Secretory Protein E4
Trial Information
Serum Concentration of HE4, a New Marker for Ovarian Cancer, Changes Little Throughout IVF Stimulation
Inclusion Criteria:
- infertility treated by IVF
Exclusion Criteria:
- pelvic tumor
- overweight (BMI over 35)
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Antti H Perheentupa, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Department of Obstetrics and Gynecology, Turku University Hospital
Authority:
Finland: Ethics Committee
Study ID:
FHE4-2010
NCT ID:
NCT01576744
Start Date:
March 2010
Completion Date:
Related Keywords:
- IVF Treatment
- Human Epididymal Secretory Protein E4
- HE4
- IVF
- Biomarker
- Ovarian cancer
- Infertility
- Ovarian Neoplasms
Name | Location |
|---|
